Action Bolt Biotherapeutics - BOLT

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

0,5126

Prix Achat

0,475

Prix Vente

0,598

Volume échangé

57 951

0,511 Fourchette du Jour 0,52

0,475 Plage de 52 semaines 1,56

Cap du marché

19,619M

Clôture Veille

0,521

Ouverture

0,5192

Dernière Transaction

0.5115

Dernière heure de transaction

Volume financier

US$ 29 799

VWAP

0,51421

Volume moyen (3 m)

165 286

Actions en circulation

38 273 002

Rendement du Dividende

Ratio Cours sur Bénéfices

-0,28

Bénéfice par action (BPA)

-1,81

Chiffre d'affairess

7,88M

Bénéfice net

-69,2M

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems.

Secteur

Pharmaceutical Preparations

Industrie

Pharmaceutical Preparations

Site Web

www.boltbio.com

Siège social

Dover, Delaware, USA

Fondé

Bolt Biotherapeutics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker BOLT. Le dernier cours de clôture d'Bolt Biotherapeutics était de US$0,52. Au cours de la dernière année, les actions de Bolt Biotherapeutics ont été négociées dans une fourchette de prix de US$ 0,475 à US$ 1,56.

Bolt Biotherapeutics compte actuellement 38 273 002 actions en circulation. La capitalisation boursière d'Bolt Biotherapeutics est de US$19,94 million. Bolt Biotherapeutics a un ratio cours/bénéfice (ratio PE) de -0.28.

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Bolt Biotherapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Advanced to the highest dose level in the Phase 1 dose-escalation clinical study of BDC-3042 in patients with advanced cancersPresented updated preclinical activity of BDC-4182 and key learnings...

Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting

BDC-4182 demonstrated compelling anti-tumor activity and an acceptable safety profile in preclinical studies BDC-4182 outperformed cytotoxic claudin 18.2 ADCs in syngeneic model Learnings from...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-0.0574	-10.0701754386	0.57	0.57	0.495	162676	0.52350952	CS
4	0.0055	1.08459869848	0.5071	0.62	0.475	188641	0.54476169	CS
12	-0.1374	-21.1384615385	0.65	0.718	0.475	165286	0.57337296	CS
26	-0.2324	-31.1946308725	0.745	0.78	0.475	163294	0.62941522	CS
52	-0.5574	-52.0934579439	1.07	1.56	0.475	170733	0.81046871	CS
156	-3.3874	-86.8564102564	3.9	4.1	0.475	185746	1.46277309	CS
260	-21.4774	-97.6689404275	21.99	43.07	0.475	190088	6.46520925	CS

BOLT - Frequently Asked Questions (FAQ)

What is the current Bolt Biotherapeutics share price?

The current share price of Bolt Biotherapeutics is US$ 0,5126

How many Bolt Biotherapeutics shares are in issue?

Bolt Biotherapeutics has 38 273 002 shares in issue

What is the market cap of Bolt Biotherapeutics?

The market capitalisation of Bolt Biotherapeutics is USD 19,94M

What is the 1 year trading range for Bolt Biotherapeutics share price?

Bolt Biotherapeutics has traded in the range of US$ 0,475 to US$ 1,56 during the past year

What is the PE ratio of Bolt Biotherapeutics?

The price to earnings ratio of Bolt Biotherapeutics is -0,28

What is the cash to sales ratio of Bolt Biotherapeutics?

The cash to sales ratio of Bolt Biotherapeutics is 2,48

What is the reporting currency for Bolt Biotherapeutics?

Bolt Biotherapeutics reports financial results in USD

What is the latest annual turnover for Bolt Biotherapeutics?

The latest annual turnover of Bolt Biotherapeutics is USD 7,88M

What is the latest annual profit for Bolt Biotherapeutics?

The latest annual profit of Bolt Biotherapeutics is USD -69,2M

What is the registered address of Bolt Biotherapeutics?

The registered address for Bolt Biotherapeutics is 3500 S DUPONT HWY, KENT, DOVER, DELAWARE, 19901

What is the Bolt Biotherapeutics website address?

The website address for Bolt Biotherapeutics is www.boltbio.com

Which industry sector does Bolt Biotherapeutics operate in?

Bolt Biotherapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
BTCTBTC Digital Ltd	US$ 8,2697 (73,73%)	61,45M
BDMDBaird Medical Investment Holdings Ltd	US$ 8,80 (62,36%)	18,63M
CRKNCrown Electrokinetics Corporation	US$ 0,1235 (54,96%)	764,86M
NUKKNukkleus Inc	US$ 29,97 (45,98%)	19,09M
GSITGSI Technology	US$ 3,97 (44,36%)	87,7M
DOGZDogness International Corporation	US$ 18,23 (-58,77%)	740,45k
ORKTOrangeKloud Technology Inc	US$ 3,02 (-24,88%)	21,08M
PMAXPowell Max Ltd	US$ 0,6364 (-23,31%)	4,17M
LGCBLinkage Global Inc	US$ 0,2876 (-22,27%)	890,66k
YYAIConnexa Sports Technologies Inc	US$ 0,8299 (-20,20%)	602,48k
CRKNCrown Electrokinetics Corporation	US$ 0,1235 (54,96%)	764,86M
GCTKGlucoTrack Inc	US$ 0,0852 (15,45%)	465,22M
RIMEAlgorhythm Holdings Inc	US$ 0,0406 (-4,02%)	387,23M
TGLTreasure Global Inc	US$ 0,2459 (14,75%)	267,1M
NVDANVIDIA Corporation	US$ 137,71 (3,10%)	201,4M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Bolt Biotherapeutics Inc (BOLT) Cours

Bolt Biotherapeutics Inc (BOLT)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

À propos de Bolt Biotherapeutics Inc

BOLT Dernières nouvelles

BOLT - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application